Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 372841 - 372860 out of 488873 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (C09DB01) valsartan and amlodipine | SENERGY 5 MG/160 MG F.C. TABLET | 30 Blister, 160,5 mg, Oral use, Film-coated tablet, 160,5mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | UNITEDPHARMACEUTICALCO. / UNITEDPHARMACEUTICALCOMPANY |
| Saudi Arabia | (C09DB01) valsartan and amlodipine | Vittoria | 28 Blister, 160,10 mg, Oral use, Film-coated tablet, 160,10mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JAMJOOMPHARMACEUTICALSCOMPANY / JAMJOOMPHARMACEUTICALSCOMPANY |
| Saudi Arabia | (C09DB01) valsartan and amlodipine | Vittoria | 28 Blister, 320,5 mg, Oral use, Film-coated tablet, 320,5mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JAMJOOMPHARMACEUTICALSCOMPANY / JAMJOOMPHARMACEUTICALSCOMPANY |
| Saudi Arabia | (C09DB01) valsartan and amlodipine | Vittoria | 28 Blister, 160,5 mg, Oral use, Film-coated tablet, 160,5mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JAMJOOMPHARMACEUTICALSCOMPANY / JAMJOOMPHARMACEUTICALSCOMPANY |
| Saudi Arabia | (J01CR02) amoxicillin and beta-lactamase inhibitor (adm: P, refers to amoxicillin) | MOXICLAV 1 gm Film Coted Tablet | 14 Blister, 875,125 mg, Oral use, Film-coated tablet, 875,125mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MEDOCHEMIELTDPHARMACEUTICALINDUSTRY / MEDOCHEMIELTD(FACTORYB) |
| Saudi Arabia | (J01CR02) amoxicillin and beta-lactamase inhibitor (adm: P, refers to amoxicillin) | AMOXIPLUS 1.2GM Powder for injection | 50 Vial, 1,2g, 1000,200 g, Parenteral use, powder for solution for injection, 1000,200g , Vial, powder for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | ANTIBIOTICS.E / ANTIBIOTICS.E |
| Saudi Arabia | (J01CR02) amoxicillin and beta-lactamase inhibitor (adm: P, refers to amoxicillin) | JULMENTIN ES SUSPENSION | 1 Bottle, 100ml, 600,42.9 mg/ml, Oral use, Powder for oral suspension, 600,42.9mg/ml , Bottle, Powder for oral suspension | Retail price without vat |
$0-0 |
$0-0 |
n/a | GulfPharmaceuticalIndustries(Julphar) / GulfPharmaceuticalIndustries(Julphar) |
| Saudi Arabia | (J01CR02) amoxicillin and beta-lactamase inhibitor (adm: P, refers to amoxicillin) | MEGAMOX 312MG SUSP | 100 Bottle, 1ml, 250,62.5 mg/ml, Oral use, Powder for oral suspension, 250,62.5mg/ml , Bottle, Powder for oral suspension | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / JazeeraPharmaceuticalIndustries(JPI) |
| Saudi Arabia | (J01FA06) roxithromycin | ROXAMED | 10 Blister, 150 mg, Oral use, Film-coated tablet, 150mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | DARALDAWA / DARALDAWA |
| Saudi Arabia | (J02AC05) isavuconazole | CRESEMBA 100MG CAPSULE | 14 Blister, 100 mg, Oral use, Capsule, hard, 100mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Aspergillosis | JazeeraPharmaceuticalIndustries(JPI) / SwissCoServicesAG |
| Saudi Arabia | (J02AC05) isavuconazole | CRESEMBA 200MG VIAL | 1 Vial, 200 mg, Intravenous use, Powder for concentrate for solution for infusion, 200mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Aspergillosis | JazeeraPharmaceuticalIndustries(JPI) / BaxterPharmaceuticalSolutions,LLC |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | HYQVIA 100MG/ML SOLUTION FOR INFUSION | 1 Vial, 50ml, 10 %, Subcutaneous use, Solution for infusion, 10% , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Immunologic Deficiency Syndromes | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | HYQVIA 100MG/ML SOLUTION FOR INFUSION | 1 Vial, 100ml, 10 %, Subcutaneous use, Solution for infusion, 10% , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Immunologic Deficiency Syndromes | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | HYQVIA 100MG/ML SOLUTION FOR INFUSION | 1 Vial, 200ml, 10 %, Subcutaneous use, Solution for infusion, 10% , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Immunologic Deficiency Syndromes | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | HYQVIA 100MG/ML SOLUTION FOR INFUSION | 1 Vial, 300ml, 10 %, Subcutaneous use, Solution for infusion, 10% , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Immunologic Deficiency Syndromes | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J06BA01) immunoglobulins, normal human, for extravascular adm. | HYQVIA 100MG/ML SOLUTION FOR INFUSION | 1 Vial, 25ml, 10 %, Subcutaneous use, Solution for infusion, 10% , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Immunologic Deficiency Syndromes | BaxaltaInnovationsGmbH / BaxaltaBelgiumManufacturingSA |
| Saudi Arabia | (J07BX03) covid-19 vaccines | Pfizer-BioNTech COVID-19 Vaccine Bivalent | 10 Vial, 0.1 mg/ml, Intramuscular use, Solution for injection, 0.1mg/ml , Vial, Solution for injection | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | PFIZERSAUDILIMITED / PfizerManufacturingBelgiumN.V. |
| Saudi Arabia | (L01EG02) everolimus (neoplastic diseases) | Avrolem | 28 Blister, 5 mg, Oral use, Tablet, 5mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | TabukPharmaceuticalManufacturingCompany / BioconLimited |
| Saudi Arabia | (L01EG02) everolimus (neoplastic diseases) | Avrolem | 28 Blister, 2.5 mg, Oral use, Tablet, 2.5mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | TabukPharmaceuticalManufacturingCompany / BioconLimited |
| Saudi Arabia | (L01EG02) everolimus (neoplastic diseases) | AFINITOR 5 MG TABLET | 30 Blister, 5 mg, Oral use, Tablet, 5mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTIS / NOVARTIS |
Pages
